INTRODUCTION
Characteristics of the terminal stages of apoptosis are genomic DNA fragmentation and chromatin condensation (reviewed in Ref. 1) . Although internucleosomal DNA breakdown is often temporally correlated with such chromatin condensation, it is not absolutely required to trigger this event (2) (3) (4) . Three pathways have been identified that mediate apoptotic chromatin condensation: (i) A caspase-3 independent pathway triggered by mitochondrial AIF 1 , which leads to an accompanying large-scale DNA fragmentation without internucleosomal DNA cleavage (5); (ii) A caspase-3 dependent pathway triggered by the protein acinus, which occurs without inducing any DNA fragmentation (6) ; and (iii) A caspase-3 dependent pathway that leads to internucleosomal DNA cleavage mediated by activated DFF, also termed CAD or CPAN (7) (8) (9) (10) (11) .
Although little is known regarding the mechanisms that lead to chromatin condensation in apoptotic cells, considerable information has appeared in the literature on the components that are linked to chromatin condensation in non-apoptotic cells. In interphase nuclei, heterochromatic regions are often associated with specific chromosomal proteins, post-translational modifications, and methylated DNA (reviewed in Refs. [12] [13] [14] . In mitotic cells, chromosome condensation requires post-translational modifications and the action of an ATP-dependent complex called "condensin" to introduce positive DNA supercoils into DNA substrates in the presence of topoisomerases (15; reviewed in ref. 16 ). In summary, many parameters and protein factors have been associated with the formation of heterochromatin and condensation of mitotic chromosomes, but which, if any of these apply to chromatin condensation during apoptosis remains to be determined.
Here we investigate the mechanism of chromatin condensation mediated by the internucleosomal DNA cleavage pathway in apoptosis. Previously we demonstrated that purified activated recombinant DFF triggered chromatin condensation when added to nuclei isolated from non-apoptotic cells (8) . In the present study we have exploited this observation to dissect the mechanism of condensation triggered by internucleosomal DNA fragmentation using the well by guest on November 15, 2017 http://www.jbc.org/ Downloaded from 5 established model of isolated HeLa cell nuclei for in vitro reconstitution experiments of apoptotic events (7, 17) . Where possible we have complemented our in vitro findings by utilizing cultured human leukemic HL-60 cells triggered to undergo apoptosis with etoposide or cisplatin (18) . Our results reveal that chromatin condensation under physiological ionic strength requires intranuclear mobility, which is allowed by the apparent disruption of components that may compartmentalize chromosome subdomains in normal cells. In addition, such condensation requires intact nucleosomes.
EXPERIMENTAL PROCEDURES
Cell culture and Treatment. Human lymphoblastoid HL-60 cells, cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, were exposed to etoposide (Bristol-Myers) or cisplatin (Ebewe) at final concentrations of 34 and 27 µM, for 6 and 12 h, respectively. In some experiments, DNA minor groove-binding drugs or actin-binding drugs (at concentrations indicated in text) were added to medium 30 min prior to etoposide. Cells were then washed with PBS buffer, fixed with 10% formaldehyde for 1 h at 4 o C, washed with PBS and then transferred onto microscope slides, dried and stained with 10 µM DAPI. DNA from portions of PBS-washed cells was purified and analyzed by agarose gel electrophoresis as described below. For labeling replicating DNA, 200 µM each of BrdU and deoxycytidine were added to the above media and after 10 h cells were pelleted, resupended in fresh media and treated with drugs as above for 6 h.
Samples that were fixed with 10% formaldehyde for 10 min were used for detection of BrdUlabeled DNA as described elsewhere (19 with chromatin condensation in these samples, and likewise in nuclei isolated from untreated HL-60 cells (Fig. 1 ). In agreement with our previous results (8), the morphology of nuclei in cells undergoing apoptosis was similar to that induced in nuclei isolated from normal cells after DFF treatment, as visualized by fluorescent microscopy after DNA staining with DAPI (Fig. 1B ). In the context of the work reported here, we will refer to this morphology as that representing "chromatin condensation", which we define as the coalescence of chromatin into distinct clumps localized mostly at the nuclear periphery. However, such condensation was not DFF-specific, because DNA fragmentation either by micrococcal nuclease (MNase), DNase I, AluI, or even the radiomimetic antibiotic bleomycin (BLM) (reviewed in Ref. 23) , also led to chromatin condensation (Fig. 1B) . We have also found in this in vitro system that the extent of condensation correlated with the degree of DNA fragmentation and that condensation could be observed within 5 min if high levels of nuclease were used; endonuclease G, another protein involved in apoptotic DNA breakdown (24) , was also effective at inducing chromatin condensation (data not shown).
Chromatin condensation could also be induced in nuclei of cells treated with nuclease in situ after cytoplasmic membrane perforation ( 
Chromatin Condensation is Energy Independent and Requires Physiological

Concentrations of Mono-and Divalent Cations-Mitotic chromosome condensation requires ATP
hydrolysis (15), and an ATP requirement has been found for certain apoptotic cell extracts to trigger chromatin condensation (27) . We therefore investigated the energy requirements for condensation in nuclei isolated from non-apoptotic HeLa cells. Nucleosomal DNA laddering mediated by either DFF or MNase was independent of the presence of ATP, ATPγS or apyrase ( Fig. 2A , lanes 3-6 and 8-11) but was blocked by 1 mM ZnCl 2 ( Fig. 2A , lanes 2,7), a known potent inhibitor of nucleases (11, 21) . In addition, varied KCl concentrations slightly modulated such laddering (low [KCl] stimulated MNase but decreased DFF activity) (Fig. 2C ). Chromatin condensation in these same samples was manifested only when DNA laddering had occurred and was not inhibited by ATPγS, apyrase ( Fig. 2A,B ), or AMP-PNP (data not shown). Furthermore, condensation mediated either by DFF or MNase was less evident at lower KCl concentrations (Fig. 2D , compare subpanels 1 and 2, and 3 and 4) and could be largely reversed by addition of reversibility of condensation to changes in the concentrations of mono-and divalent ions is not unexpected, because previous studies have shown that even isolated mononucleosomes bearing histone H1 can be quantitatively precipitated by exposure to either 100 mM KCl or 5 mM MgCl 2 , and subsequently reversibly quantitatively solubilized by exposure to low ionic strengths and EDTA (28, 29) . Nevertheless, we conclude that coalescing of fragmented chromatin into condensed clumps is energy independent and optimal under physiological ionic strengths.
Chromatin Condensation is Blocked by Stabilization of Internal Nuclear Components-In
considering the mechanism of chromatin condensation in our in vitro system, it seems clear that digested chromatin fragments need to be able to diffuse within isolated nuclei in order to coalesce into clumps of condensed chromatin. However, nuclei within living cells are known to be organized into subcompartments, which have established territories for individual chromosomes and limit chromatin segment movement to nuclear subregions (30; reviewed in Refs. 12, 31-33).
Possibly this internal nuclear organization becomes altered during the processes of cell lysis and nuclei isolation such that intranuclear diffusion of chromatin fragments becomes possible. Indeed, during apoptosis in cultured cells the accompanying proteolysis of nuclear lamins and other nuclear proteins leads to disorganization of nuclear subcompartments (25, 34, 35) .
To test the idea that dissolution of internal nuclear structure is required for chromatin condensation in our in vitro system, we took advantage of the observations made by Laemmli and co-workers that reversible treatment with Ca 2+ or Cu 2+ stabilize DNA attachment sites both in concentrations of Ca 2+ (4-9 mM for interphase nuclei, and 20-32 mM for mitotic chromosomes), which are at 3-fold higher levels than those of Mg 2+ ions; furthermore, such Ca 2+ is enriched in the chromosomal axis and co-localizes with the scaffolding proteins topo II and ScII (42) . We also used two other techniques to stabilize internal nuclear components, exposure of nuclei to mild oxidation to generate disulfide bonds within and between protein species (reviewed by in Refs.
39-41), and exposure of nuclei to pH 4.0 followed by neutralization to pH 7.5 (our empirical observation). As shown in Fig. 3A , these pre-treatments did not significantly disrupt chromatin structure as revealed by the patterns of DNA laddering generated by subsequent digestion with MNase ( Significantly, all pre-treatments that blocked chromatin condensation in isolated nuclei affected the extractability of nuclear proteins by 0.2-and 0.35-M NaCl. Either reversible treatment with CaCl 2 , diamide or low pH significantly reduced the amount of released protein, while CuCl 2 pretreatment almost totally prevented nuclear protein release (Fig. 3C ). In conclusion, enhancing metalloprotein interactions, inducing disulfide bond formation, and apparent protein denaturation caused by reversible low pH treatment each apparently stabilize internal nuclear components and thereby disallow digested chromatin fragments the intranuclear mobility required for coalescence into clumps of condensed chromatin. (43, 44) . As shown in Fig. 4A , treatment of nuclei with these reagents did not significantly disrupt chromatin structure as revealed by the patterns of DNA laddering. Actin is a known inhibitor of DNase I, which depolymerizes F-actin (45) . Significantly, treatment of nuclei with phalloidin markedly increased the sensitivity of chromatin to DNase I digestion (Fig. 4A) ; reversible exposure of nuclei to pH 4 (but not pre-treatment with diamide, CaCl 2 or CuCl 2 ) also sensitized nuclei to DNase I digestion (data not shown). Furthermore, phalloidin treatment partially inhibited chromatin condensation (Fig. 4B, subpanel 2) . It is known that phalloidin will cause the formation of F-actin from G-actin (44) . However, the partial inhibition caused by phalloidin was apparently not due to causing this conversion because a similar extent of inhibition was observed when latrunculin A was added at the same time to block F-actin formation (Fig. 4B, subpanel 4 ). Although such inhibition was detected in only ~30% of the nuclei, it proved to be highly reproducible and statistically significant (P < 0.05). In addition, use of jasplakinolide, another reagent known to stabilize F-actin (46), gave the same degree of partial inhibition of condensation (data not shown). Furthermore, chromatin condensation in control nuclei could not be reversed if the phalloidin treatment occurred after nuclease digestion (data not shown). Interestingly, if the nuclei were first extracted with 0.35 M salt, a condition leading to ~60% loss of nuclear actin, chromatin condensation could no longer be partially inhibited by phalloidin (data not shown). We also analyzed nuclear proteins released from MNase-digested nuclei by SDS-PAGE and actin by Western blotting (Fig. 4C,D) . Concomitant with the by guest on November 15, 2017
http://www.jbc.org/ Downloaded from condensation process we found that >80% of the nuclear actin was lost from control nuclei, or nuclei pre-treated with latrunculin A (Fig. 4C,D, lanes 1,2,5,6) . Significantly, such a loss was blocked by reversible exposure to pH 4 ( Fig. 4D, lanes 9,10) , as well as by pre-treatment with CaCl 2 (Fig. 4D, lanes 7,8) , CuCl 2 (Fig. 4D, lanes 11,12) or diamide (Fig. 4D, lanes 13,14) .
Interestingly, phalloidin treatment only partially blocked actin release (Fig. 4C,D, lanes 3,4) . This correlates with the observation that phalloidin treatment only fractionally inhibited condensation, unlike pH 4, CuCl 2 , or diamide. Taken together, these results suggest that F-actin partially restricts chromatin fragment mobility for condensation.
We also assayed actin-targeting reagents for their ability to block chromatin condensation in cultured HL-60 cells triggered to undergo apoptosis by etoposide. We selected jasplakinolide to stabilize F-actin because it is much more permeable to cells than phalloidin (46) , and latrunculin A which targets G-actin (43). Because we found that the drugs were quite toxic to cells we had to perform experiments with reagents diluted to 0.3 µM. Under these conditions we found that jasplakinolide (±latrunculin A) treatment did not affect DNA laddering induced by etoposide (Fig. 4E, lane 5,6 ), whereas these drugs reduced chromatin condensation about 20% compared to the etoposide-treated control (70% and 69% vs. 89%) (Fig. 4F, subpanels 4,5,6 ).
Jasplakinolide by itself also induced minor DNA breakdown (Fig. 4E, lane 2) , which is in agreement with a previous report that the reagent enhances apoptosis (47 of the cells had incorporated BrdU. Significantly, in this cell population ~50% of the nuclei with condensed chromatin contained newly synthesized DNA, while only ~5% of the cells that lacked condensed chromatin were labeled with BrdU (Fig. 4G) . Therefore, stabilization of F-actin is primarily inhibitory of apoptotic chromatin condensation in non-S-phase cells.
Agents that Target the DNA Minor Groove Block Chromatin Condensation
In order to dissect further the mechanism of chromatin condensation in our in vitro system we searched empirically for other reagents that could uncouple condensation from DNA fragmentation at physiological ionic strengths. We selected for study agents that bind to or intercalate into either the minor or major grooves of DNA, including: distamycin A and bisbenzimide (Hoechst 33258), which preferentially bind to the minor groove of AT-rich DNA (50, 51); chromomycin A 3 , which preferentially binds to the minor groove of GC-rich DNA (52, 53) ; ethidium bromide, which intercalates into the DNA minor groove (54); and methyl green, which binds to the DNA major groove (55) . As shown in Fig. 5 , several of these reagents blocked condensation without inhibiting DNA fragmentation. With the exception of ethidium bromide (Fig. 5A, lane 7) , incubation of nuclei with any of the DNA-binding compounds did not markedly disrupt chromatin structure as revealed by the patterns of DNA laddering on a low resolution agarose gel (Fig. 5A ). Because ethidium bromide is known to perturb chromatin structure (56) , this result was not unexpected.
Both distamycin A and bisbenzimide, but not chromomycin A 3 or ethidium bromide, however, affected the rate of digestion ( Analysis of the dose response of the inhibitory reagents reveals that 50% inhibition of condensation occurs between 20-and 50-µM drug (Fig. 5C ). We have quantitated spectrophotometrically the amount of these reagents that bind to nuclei at 50% inhibition, and estimate that if all reagent that is bound to nuclei is associated with DNA that 1 molecule of drug would exist for every 10-20 bp. One would expect that DNA wrapping about and within by guest on November 15, 2017 http://www.jbc.org/ Downloaded from nucleosomes might be disrupted at these levels of drug, although we did not see any disruption of the nucleosomal repeat on a low resolution gel, with the exception of ethidium bromide treatment (Fig. 5A) . However, analysis of digestion products on a higher resolution acrylamide gel reveals that the 146 bp barrier, which is a characteristic of the nucleosome core particle (57) , is lost at drug concentrations that block condensation, and there is a higher internucleosomal band background, indicating that the drugs increase nuclease cleavage within nucleosomes (Fig. 5D ).
To examine alterations in DNA wrapping caused by these reagents in more detail, we assayed for the intactness of the ~10 base subnucleosomal DNA repeat that is generated by DNase I digestion of chromatin (57, 58) . As shown in Fig. 5E , this subnucleosomal DNA repeat is also disrupted by the inhibitory drugs, as evidenced by a higher interband background. By contrast, no detectable disruption in nucleosomal DNA wrapping was observed at even 100 µM methyl green, a concentration which we estimate from what bound to nuclei would represent roughly 1 molecule of drug for every 20 bp (Fig. 5E ). Although similar concentrations of minor groove drugs were toxic to HL-60 cells, at lower doses they were partially inhibitory to etoposide-induced apoptotic condensation (data not shown). We conclude that intact nucleosomes are required for chromatin condensation in our system.
DISCUSSION
Conflicting reports exist in the literature on whether DNA cleavage of nuclei isolated from non-apoptotic cells by any nuclease can lead to chromatin condensation nearly mimicking that seen in apoptotic cells (2, 5, 33, 59, 60) . If this indeed were true, then a model in vitro system could be established to dissect the requirements for this process. Here we have successfully developed such a system. We provide also an explanation for discrepancies in
the literature because we demonstrate that such condensation requires mono-and divalent metal ions at physiological ionic strengths; conditions not always used by other investigators. It should also be noted that the nature of DNA fragment ends is not important, as condensation can occur with components possessing blunt ends, with 5' or 3'
overhangs, and with either 5' or 3' phosphate groups.
Condensation Apparently Requires Disruption of Nuclear Sub-compartmentalization-We have evidence
that chromatin condensation in our in vitro system requires intranuclear mobility mediated by the disruption of components that may participate in the subcompartmentalization of chromosomal subdomains in living cells. We found that enhancing metalloprotein interactions, inducing disulfide bond formation, or apparent protein denaturation caused by reversible low pH treatment each were effective in blocking chromatin condensation. These treatments inhibit condensation by a mechanism different from the drugs that target the DNA minor groove because we have found that the subnucleosomal DNase I-generated ladder remains intact in such treated nuclei (data not shown). In only one of these four conditions (low pH), pre-extraction of nuclei with 0.35 M NaCl eliminated the block in apparent intranuclear mobility (data not shown).
While it can be argued that these stabilization treatments are quite harsh and may lead to artifacts, stabilization of nuclear F-actin led to partial inhibition of chromatin condensation, both in vitro and in vivo, strongly supporting the notion that disruption of intranuclear organization is indeed required for chromatin condensation. Furthermore, leakage of nuclear actin was markedly reduced, either by pH 4, Ca
2+
, Cu 2+ or diamide pre-treatments, conditions that each severely inhibited chromatin condensation. Interestingly, previous micro-dissection experiments with
Xenopus oocytes have revealed that even after mechanical removal of the nuclear envelope, chromosome organization is maintained by a "nucleoplasmic gel" that contains both F-and Gactin as major components (61, 62) . Indeed, it is now appreciated that nuclear actin plays roles in chromatin remodeling and RNA transcript trafficking (63, 64) . Furthermore, certain actin-binding proteins interact with a fibrous network in the nucleoplasm (64, 65) . We propose that nuclear actin also participates in establishing chromosomal territories that restrict chromatin fragment mobility. Stabilization of F-actin, however, was ineffective in blocking chromatin condensation in cells replicating their genomes. This suggests that the apparent intranuclear mobility of chromatin is less restricted by F-actin during S phase of the cell cycle. It is of further interest that actin is a known substrate for caspase-3 during apoptosis (66) .
Condensation Likely Requires Preservation of Native Nucleosomal DNA Wrapping through Core
Histone:DNA Minor Groove Contacts-It is striking that agents that target the minor groove of DNA inhibit chromatin condensation, both in vitro and in vivo. These agents inhibit condensation by a pathway not linked to actin retention (data not shown). Distamycin A and bisbenzimide preferentially bind to the minor groove of AT-rich DNA, eliminate the known preferential association of histone H1 with AT-rich DNA (67, 68) and cause decondensation of heterochromatin (69, 70) . However, chromomycin A 3 , which preferentially binds to the minor groove of GC-rich DNA was also effective in blocking condensation. We have searched by SDS-PAGE for proteins that might be released from nuclei by ethidium, distamycin A or chromomycin A 3 treatment, but found no evidence for release or weakened interactions with DNA of any protein species under conditions that blocked condensation (data not shown). Nuclease protection assays however, have revealed that these inhibitory drugs alter nucleosomal DNA wrapping. The globular domain of histone H1 binds to the major groove of DNA (71, 72) , whereas core histones bind to the minor groove (73) . Native nucleosomal DNA wrapping through core histone interactions therefore seems to be required for nucleosomes to assemble into higher order structures that lead to chromatin condensation. This wrapping is known to neutralize positively-charged amino acids by a close association with negatively-charged DNA phosphate groups. However, simple electrostatic repulsion between chromatin fragments can not be the mechanism behind the inhibition of condensation mediated by these drugs, because neither distamycin A nor ethidium bromide (at up to 200 µM concentrations) prevented precipitation of isolated oligonucleosomes (1 to 8-mers) induced by 4 mM MgCl 2 and 100 mM KCl (data not shown). Thus, it appears that these drugs affect the ability of chromatin fragments to coalesce, possibly by promoting interactions between the drug-induced exposed positively-charged amino acids and acidic non-histone proteins, which may interfere with inter-nucleosome interactions and/or fragment diffusion. It is interesting to reflect from an evolutionary view that nucleosome structure not only fulfills crucial regulatory and packaging roles in living cells, but also prepares apoptotic cells for the efficient clearance of DNA by phagocytosis during cell death. Although not known at present, we favor the notion that the condensation process that we observe represents a specific form(s) of stacking of nucleosomes into supramolecular structures, rather than non-specific aggregation phenomena. Indeed, it has been recently shown that at high concentrations of nucleosome core particles (350 mg/ml), which is similar to their intranuclear level, nucleosomes stack into aligned columns that form bilayers constituting a liquid crystalline state (74) .
Extensive earlier investigations have demonstrated that histone H1 facilitates higher-order chromatin packing (75; reviewed in Ref. 76) , and confers insolubility even to mononucleosomes at physiological ionic strengths (28, 29) . The observed ionic strength dependency on chromatin condensation is consistent with a role for histone H1 in this process. Furthermore, it is known that histone H1-minus-nucleosomes leak out of MNase-digested-nuclei under physiological ionic strengths (77) . To determine if condensation could be inhibited by depleting nuclei of histone H1
prior to DNA fragmentation, we extracted nuclei either at low pH (22) , with polyglutamic acid (68), or with 0.6 M NaCl. However, in our hands we found that these procedures were either inefficient or disruptive to nuclear integrity (data not shown).
Neither Topo II Activity nor ATP are Required for Condensation-Distamycin A is also known to inhibit the preferential interaction of topo II with AT-rich DNA (78) . Topo II has been associated with mitotic chromosome condensation in normal cells (79) (80) (81) , with heterochromatin formation in interphase nuclei (82) , with mediating DNA aggregation in vitro (78, 83) , with chromatin condensation triggered by apoptotic cell extracts (84) , and with higher-order DNA fragmentation during apoptosis (85). In addition, previous studies have shown that ATP is required for chromatin condensation but not for internucleosomal DNA fragmentation when apoptotic cell extracts are added to isolated nuclei from non-apoptotic cells (27) . However, inhibition of topo II activity or depletion of ATP were ineffective in blocking chromatin condensation in our experiments with isolated nuclei. Therefore we suggest that in these earlier studies the topo II and ATP requirements may play a role in eliminating inhibitors present in apoptotic cell extracts. 
